Page 57 - Read Online

Lu et al. Microbiome Res Rep 2024;3:17 https://dx.doi.org/10.20517/mrr.2023.44 Page 13 of 14

of Lipid Metabolism. Int J Biol Sci 2020;16:2308-22. DOI PubMed PMC
83. Zambusi A, Novoselc KT, Hutten S, et al. TDP-43 condensates and lipid droplets regulate the reactivity of microglia and regeneration
after traumatic brain injury. Nat Neurosci 2022;25:1608-25. DOI
84. Gluchowski NL, Becuwe M, Walther TC, Farese RV Jr. Lipid droplets and liver disease: from basic biology to clinical implications.
Nat Rev Gastroenterol Hepatol 2017;14:343-55. DOI PubMed PMC
85. Mao K, Baptista AP, Tamoutounour S, et al. Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid
metabolism. Nature 2018;554:255-9. DOI
86. Fathallah-Shaykh SA, Cramer MT. Uric acid and the kidney. Pediatr Nephrol 2014;29:999-1008. DOI PubMed
87. Sari DCR, Soetoko AS, Soetoko AS, et al. Uric acid induces liver fibrosis through activation of inflammatory mediators and
proliferating hepatic stellate cell in mice. Med J Malaysia 2020;75:14-8. PubMed
88. Latourte A, Dumurgier J, Paquet C, Richette P. Hyperuricemia, gout, and the brain - an update. Curr Rheumatol Rep 2021;23:82. DOI
PubMed
89. Koch M, De Keyser J. Uric acid in multiple sclerosis. Neurol Res 2006;28:316-9. DOI
90. Wei X, Zhang M, Huang S, et al. Hyperuricemia: a key contributor to endothelial dysfunction in cardiovascular diseases. FASEB J
2023;37:e23012. DOI
91. Méndez-Salazar EO, Martínez-Nava GA. Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in
gout development. Rheumatol Int 2022;42:403-12. DOI PubMed
92. Zhang L, Liu J, Jin T, Qin N, Ren X, Xia X. Live and pasteurized Akkermansia muciniphila attenuate hyperuricemia in mice through
modulating uric acid metabolism, inflammation, and gut microbiota. Food Funct 2022;13:12412-25. DOI
93. Duan Z, Fu J, Zhang F, et al. The association between BMI and serum uric acid is partially mediated by gut microbiota. Microbiol
Spectr 2023;11:e0114023. DOI PubMed PMC
94. Xu P, Han X, Shen S, Li M. The relationship between serum uric acid level and liver function in patients with hepatitis B in China.
Clin Lab 2021:1190. DOI
95. Tang X, Song ZH, Cardoso MA, Zhou JB, Simó R. The relationship between uric acid and brain health from observational studies.
Metab Brain Dis 2022;37:1989-2003. DOI
96. Huang TT, Hao DL, Wu BN, Mao LL, Zhang J. Uric acid demonstrates neuroprotective effect on Parkinson’s disease mice through
Nrf2-ARE signaling pathway. Biochem Biophys Res Commun 2017;493:1443-9. DOI PubMed
97. Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F. Uric acid and endothelial dysfunction in essential hypertension. J Am Soc
Nephrol 2006;17:1466-71. DOI PubMed
98. Xiao J, Zhang XL, Fu C, et al. Soluble uric acid increases NALP3 inflammasome and interleukin-1β expression in human primary
renal proximal tubule epithelial cells through the Toll-like receptor 4-mediated pathway. Int J Mol Med 2015;35:1347-54. DOI
99. Watanabe T, Ishikawa M, Abe K, et al. Increased lung uric acid deteriorates pulmonary arterial hypertension. J Am Heart Assoc
2021;10:e022712. DOI PubMed PMC
100. Bajaj JS, Ridlon JM, Hylemon PB, et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol
Gastrointest Liver Physiol 2012;302:G168-75. DOI PubMed PMC
101. Pan Q, Li YQ, Guo K, et al. Elderly patients with mild cognitive impairment exhibit altered gut microbiota profiles. J Immunol Res
2021;2021:5578958. DOI PubMed PMC
102. Bajaj JS, Hylemon PB, Ridlon JM, et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic
encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 2012;303:G675-85. DOI
PubMed PMC
103. Bajaj JS, Fagan A, White MB, et al. Specific gut and salivary microbiota patterns are linked with different cognitive testing strategies
in minimal hepatic encephalopathy. Am J Gastroenterol 2019;114:1080-90. DOI PubMed PMC
104. Bajaj JS, Gillevet PM, Patel NR, et al. A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy.
Metab Brain Dis 2012;27:205-15. DOI
105. Cooper AJL, Kuhara T. α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and
inborn errors of the urea cycle. Metab Brain Dis 2014;29:991-1006. DOI PubMed PMC
106. Chen F, Li J, Zhang W, et al. [Retracted] Risk factor analysis of hepatic encephalopathy and the establishment of diagnostic model.
Biomed Res Int 2022;2022:3475325. DOI PubMed PMC
107. Qi R, Zhang LJ, Luo S, et al. Default mode network functional connectivity: a promising biomarker for diagnosing minimal hepatic
encephalopathy: CONSORT-compliant article. Medicine 2014;93:e227. DOI PubMed PMC
108. Claeys W, Van Hoecke L, Lernout H, et al. Experimental hepatic encephalopathy causes early but sustained glial transcriptional
changes. J Neuroinflammation 2023;20:130. DOI PubMed PMC
109. Mincheva G, Gimenez-Garzo C, Izquierdo-Altarejos P, et al. Golexanolone, a GABA receptor modulating steroid antagonist,
A
restores motor coordination and cognitive function in hyperammonemic rats by dual effects on peripheral inflammation and
neuroinflammation. CNS Neurosci Ther 2022;28:1861-74. DOI PubMed PMC
110. Moran S, López-Sánchez M, Milke-García MDP, Rodríguez-Leal G. Current approach to treatment of minimal hepatic
encephalopathy in patients with liver cirrhosis. World J Gastroenterol 2021;27:3050-63. DOI PubMed PMC
111. Morgan TR, Moritz TE, Mendenhall CL, Haas R. Protein consumption and hepatic encephalopathy in alcoholic hepatitis. VA
Cooperative Study Group #275. J Am Coll Nutr 1995;14:152-8. DOI